Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103339130B details novel alkylation and phosphorylation routes for HIV prodrugs. Offers enhanced supply chain stability and cost reduction in pharmaceutical manufacturing.
Patent CN112680425B reveals a novel alcohol dehydrogenase mutant for producing high-purity (S)-CHBE. This biocatalytic route offers significant cost reduction and supply chain reliability for statin manufacturing.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Novel synthesis replaces toxic thiophosgene ensuring safety and high yield for scalable pharmaceutical intermediate manufacturing supply chains globally. This patent offers significant cost reduction and environmental compliance benefits for buyers.
Discover a novel catalytic preparation method for arotinolol hydrochloride. This green process offers cost reduction in pharmaceutical intermediates manufacturing and high purity.
Novel 3-step synthesis of Dronedarone intermediates via Pd/C catalysis. Offers cost reduction in API manufacturing and high-purity output for global supply chains.
Patent CN102952106A reveals high purity Escitalopram Impurity C synthesis. Offers stable reproducibility and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN102952001A offers cost-effective chiral intermediate production. Enhances supply chain reliability for Lurasidone manufacturing.
Patent CN109180518A reveals a Pd-catalyzed carbonylation route for amides. This method offers significant cost reduction in amide manufacturing and enhanced supply chain reliability for global buyers.
Novel patent CN117304043A details a high-yield esmolol hydrochloride synthesis route featuring nanowire intermediates for cost reduction in API manufacturing.
Patent CN1950326A details a high-yield optical resolution and recycling process for atomoxetine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel one-step synthesis of anticancer spiroindolinone derivatives offers high purity and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN116425824A reveals a novel solid-phase method for S-2732 synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN103214534A details improved cordycepin synthesis ensuring high purity and yield for reliable pharmaceutical intermediates supplier cost reduction.
Novel safe route for Tedizolid intermediate avoids azides. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN104371010B details a safer Fmoc solid-phase synthesis for Ganirelix. This method improves yield and purity while eliminating toxic HF usage for reliable supply.
Novel synthesis route for GABA derivative intermediates featuring high purity and mild conditions. Enables cost-effective manufacturing for global pharmaceutical supply chains.
Novel palladium-catalyzed route for fluoroalkyl substituted pyrrole indoles offers mild conditions and cost efficiency for pharmaceutical intermediate manufacturing supply chains.